Franklin Resources
FPRX

Franklin Resources’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Franklin Resources’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-438,700
Closed -$6.82M – 1604
2014
Q2 		$6.82M Hold
438,700
– – ﹤0.01% 1131
2014
Q1 		$8.63M Hold
438,700
– – ﹤0.01% 1063
2013
Q4 		$7.37M Buy
+438,700
New +$5.45M ﹤0.01% 1058

Other funds holding FPRX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources's FPRX Position: Q3 2014 in Review

Franklin Resources sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2014, closing a stake of 438,700 shares — an estimated $6.82M sold.

Franklin Resources first reported a position in FPRX in Q4 2013 and held it in 3 quarters. The position peaked at $8.63M in Q1 2014. 63 funds tracked by Wall St. Rank hold FPRX as of Q3 2014.

  • Franklin Resources reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • Franklin Resources sold 438,700 Five Prime Therapeutics, Inc. shares in Q3 2014, an estimated $6.82M.
  • Franklin Resources first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 3 quarters.
  • Franklin Resources's Five Prime Therapeutics, Inc. position peaked at $8.63M in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2014.

Based on Franklin Resources's 13F filing for Q3 2014, filed 12 Nov 2014.